RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
KMPharmaceutical Co Stock

KMPharmaceutical Co Net Income 2024

KMPharmaceutical Co Net Income

-1.32 B KRW

Ticker

225430.KQ

ISIN

KR7225430008

In 2024, KMPharmaceutical Co's profit amounted to -1.32 B KRW, a -66.37% increase from the -3.92 B KRW profit recorded in the previous year.

The KMPharmaceutical Co Net Income history

YEARNET INCOME (undefined KRW)
2023-1,320.04
2022-3,924.97
2021-611.19
2020471
2019-902
2018-12,330
201715
20167
2015-

KMPharmaceutical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into KMPharmaceutical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by KMPharmaceutical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects KMPharmaceutical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of KMPharmaceutical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into KMPharmaceutical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing KMPharmaceutical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on KMPharmaceutical Co’s growth potential.

KMPharmaceutical Co Revenue, EBIT and net profit per share

DateKMPharmaceutical Co RevenueKMPharmaceutical Co EBITKMPharmaceutical Co Net Income
202317.77 B undefined-1.09 B undefined-1.32 B undefined
202215.63 B undefined-1.25 B undefined-3.92 B undefined
202122.71 B undefined866.14 M undefined-611.19 M undefined
202022.93 B undefined712 M undefined471 M undefined
201920.34 B undefined-1.53 B undefined-902 M undefined
201817.3 B undefined1.57 B undefined-12.33 B undefined
20170 undefined-88 M undefined15 M undefined
20160 undefined-99 M undefined7 M undefined
20150 undefined-21 M undefined0 undefined

KMPharmaceutical Co stock margins

The KMPharmaceutical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of KMPharmaceutical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for KMPharmaceutical Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the KMPharmaceutical Co's sales revenue. A higher gross margin percentage indicates that the KMPharmaceutical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the KMPharmaceutical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the KMPharmaceutical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the KMPharmaceutical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the KMPharmaceutical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the KMPharmaceutical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

KMPharmaceutical Co Margin History

KMPharmaceutical Co Gross marginKMPharmaceutical Co Profit marginKMPharmaceutical Co EBIT marginKMPharmaceutical Co Profit margin
202327.63 %-6.14 %-7.43 %
202220.63 %-7.97 %-25.11 %
202124.94 %3.81 %-2.69 %
202025.91 %3.11 %2.05 %
201928.45 %-7.5 %-4.44 %
201833.49 %9.09 %-71.26 %
201727.63 %0 %0 %
201627.63 %0 %0 %
201527.63 %0 %0 %

KMPharmaceutical Co Aktienanalyse

What does KMPharmaceutical Co do?

KMPharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding KMPharmaceutical Co's Profit Margins

The profit margins of KMPharmaceutical Co represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of KMPharmaceutical Co's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating KMPharmaceutical Co's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

KMPharmaceutical Co's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When KMPharmaceutical Co’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about KMPharmaceutical Co stock

How much profit has KMPharmaceutical Co made this year?

KMPharmaceutical Co has made -1.32 B KRW this year.

How has the profit developed compared to last year?

The profit has increased by -66.37% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does KMPharmaceutical Co publish its earnings?

KMPharmaceutical Co publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of KMPharmaceutical Co?

The profits of KMPharmaceutical Co are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of KMPharmaceutical Co?

You can learn more about the earnings of KMPharmaceutical Co by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does KMPharmaceutical Co pay?

Over the past 12 months, KMPharmaceutical Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, KMPharmaceutical Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of KMPharmaceutical Co?

The current dividend yield of KMPharmaceutical Co is .

When does KMPharmaceutical Co pay dividends?

KMPharmaceutical Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of KMPharmaceutical Co?

KMPharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of KMPharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is KMPharmaceutical Co located?

KMPharmaceutical Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von KMPharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of KMPharmaceutical Co from 12/30/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 12/30/2024.

When did KMPharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/30/2024.

What was the dividend of KMPharmaceutical Co in the year 2023?

In the year 2023, KMPharmaceutical Co distributed 0 KRW as dividends.

In which currency does KMPharmaceutical Co pay out the dividend?

The dividends of KMPharmaceutical Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von KMPharmaceutical Co

Our stock analysis for KMPharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of KMPharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.